ZUH:CA:TSX-BMO Equal Weight US Health Care (CAD Hedged) (CAD)

ETF | Sector Equity |

Last Closing

CAD 73.39

Change

+0.14 (+0.19)%

Market Cap

CAD 0.27B

Volume

725.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-18 )

Largest Industry Peers for Sector Equity

Symbol Name Price(Change) Market Cap
TEC:CA TD Global Technology Leaders I..

-0.14 (-0.36%)

CAD 2.84B
ZWU:CA BMO Covered Call Utilities ETF

-0.05 (-0.45%)

CAD 1.90B
XHC:CA iShares Global Healthcare (CAD..

-0.15 (-0.20%)

CAD 0.65B
HTA:CA Harvest Tech Achievers Growth ..

-0.13 (-0.71%)

CAD 0.61B
XIT:CA iShares S&P/TSX Capped Informa..

+0.16 (+0.29%)

CAD 0.61B
TXF:CA First Asset Tech Giants Covere..

-0.12 (-0.56%)

CAD 0.60B
ZUT:CA BMO Equal Weight Utilities Ind..

-0.16 (-0.72%)

CAD 0.44B
CWW:CA iShares Global Water Common Cl..

-0.07 (-0.12%)

CAD 0.33B
XUT:CA iShares S&P/TSX Capped Utiliti..

-0.23 (-0.81%)

CAD 0.30B
COW:CA iShares Global Agriculture Com..

+0.62 (+1.00%)

CAD 0.28B

ETFs Containing ZUH:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Sector Equity) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 6.59% 26% F 39% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 6.59% 26% F 36% F
Trailing 12 Months  
Capital Gain 11.00% 46% F 44% F
Dividend Return 0.76% 27% F 16% F
Total Return 11.76% 34% F 41% F
Trailing 5 Years  
Capital Gain 36.74% 40% F 64% D
Dividend Return 2.19% 16% F 9% A-
Total Return 38.93% 31% F 59% D-
Average Annual (5 Year Horizon)  
Capital Gain 4.98% 29% F 56% F
Dividend Return 5.35% 26% F 53% F
Total Return 0.37% 28% F 26% F
Risk Return Profile  
Volatility (Standard Deviation) 16.70% 60% D- 50% F
Risk Adjusted Return 32.05% 29% F 51% F
Market Capitalization 0.27B 71% C- 50% F

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.